CureVac (CVAC), University Medical Center Mainz Start Phase 3 Clinical Trial for COVID-19 Vaccine Candidate, CVnCoV, in Healthcare Workers
Go back to CureVac (CVAC), University Medical Center Mainz Start Phase 3 Clinical Trial for COVID-19 Vaccine Candidate, CVnCoV, in Healthcare Workers| Clearview Acquisitions, Inc. (NASDAQ: CVAC) | Delayed: 2.31 -0.2 (7.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.51 | 52 Week High | $2.10 | |||
| Open | $2.48 | 52 Week Low | $1.50 | |||
| Day High | $2.48 | P/E | N/A | |||
| Day Low | $2.22 | EPS | $-0.04 | |||
| Volume | 1,242,369 | |||||
